• SPTX share price: currently unavailable. Sorry, we currently don't have enough data to create an insight.

  • Price change

    The price of SPTX shares has decreased $0.61 since the market last closed. This is a 3.24% drop.

  • Closed at $18.19.

    The stock has since risen $0.47 in after-hours trading.

Key terms

About SPTX

Seaport Therapeutics, Inc. is a clinical-stage therapeutics company, which engages in the provision of inventing and developing new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company was founded on April 1, 2024 and is headquartered in Boston, MA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
  • Market cap: $964.58M

    A market capitalization between $300 million and $2 billion places SPTX in the small capitalization category.

Key terms

Smart score

Latest SPTX news

May 26, 2026 12:06pm ET Opening Day: SpaceX submits S-1 for Nasdaq IPO by TipRanks May 26, 2026 6:24am ET Seaport Therapeutics initiated with an Outperform at Leerink by TipRanks May 26, 2026 6:10am ET Seaport Therapeutics initiated with a Buy at Citi by TipRanks May 26, 2026 5:16am ET Seaport Therapeutics initiated with a Buy at Stifel by TipRanks May 26, 2026 5:05am ET Seaport Therapeutics initiated with an Overweight at JPMorgan by TipRanks May 26, 2026 4:25am ET Seaport Therapeutics initiated with Early-Stage Biotech at Goldman Sachs by TipRanks May 04, 2026 10:08pm ET Major Investor Makes Bold New Move on Seaport Therapeutics Stock by TipRanks May 04, 2026 11:51am ET Opening Day: Pershing Square listings open soft in market debut by TipRanks May 01, 2026 12:35pm ET Seaport Therapeutics opens at $21, IPO priced at $18 per share by TipRanks May 01, 2026 7:26am ET Seaport Therapeutics 14.2M share IPO priced at $18.00 by TipRanks Apr 30, 2026 7:35pm ET Seaport Therapeutics prices 14.6M share IPO a $18, top of range, Bloomberg says by TipRanks

No recent press releases are available for SPTX

SPTX Financials

1-year income & revenue

  • SPTX total revenue: temporarily unavailable. We are sorry, but this information is temporarily unavailable.

  • SPTX net income: temporarily unavailable. We are sorry, but this information is temporarily unavailable.

  • SPTX earnings per share: temporarily unavailable. We are sorry, but this information is temporarily unavailable.

Key terms

SPTX Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

SPTX Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range
  • How competitors are chosen

    SPTX's competitors are included in the Health Technology sector and Pharmaceuticals: Major group

  • Market cap: $964.58M

    A market capitalization between $300 million and $2 billion places SPTX in the small capitalization category.

Key terms

Latest investing news